Indefinite Delivery Contract SPE2DX15D9637

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers. The contract, valued at up to $4,999,999, encompasses branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The contract, which runs through December 2025, allows the DLA to issue firm fixed-price delivery orders against the IDC as needed. The delivery orders summarized in the materials cover a diverse portfolio of pharmaceutical items, including specialized medications like Xolair, Trikafta, Keytruda, Botox, and Nucala. This contract positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites worldwide.